History


2020
Investment and commissioning of a high-performance filling machine for the effective and safe production of sample kits and assays. Development of a new diabetes testing system based on blood of healthy donors. Foundation of the IVDR-Alliance, a competence merger of the two companies Biomex GmbH and Qarad B.V.B.A., for the realization of complete solutions for the compliant implementation of the new EU IVDR regulation. Launch of the new Biomex homepage in a new, modern design. Membership in BioRN Network e.V., a competence network and biotech hub in the fields of life science, diagnostics and medicine.

2019
Joint trade fair appearance at MEDICA 2019 together with the sister companies DiaMex GmbH and ESfEQA GmbH. Product launch of Optitrol NAT controls. Expansion of the product portfolio in the field of human tissue material. Expansion and intensification of international sales activities.

2018
Planning, development and implementation of a proprietary online warehouse management platform for more transparency and effectiveness in goods management and inventory. Realization of the SampleShop, which gives customers the possibility to retrieve information about the current stock level and the availability of a rquired sample.


2006
Foundation of the plasma centre in Munich for the production of plasma for diagnostic purposes with a focus on the production of disease state plasmas (HIV, HCV, HBV, Toxo, CMV, Rubella). Certification of the plasma centre in accordance with ISO 9001: 2000. Staff of 10 employees.

2017
Development of a worldwide distributor network. Certification of a L3** laboratory.

2016
First participation at the Arab Health in Dubai. Biomex is distributor of ZeptoMetrix since May 2016. An overview of the available ZeptoMetrix panels can be found here.


2015
New in the portfolio: Prospective Clinical Collection. Staff of 70 employees. Larger area and new booth design at MEDICA.

2014
Foundation of a subsidiary in the USA (Biomex US LLC). New in the portfolio: CTS panel and studies for the approval of IvD products (list A, B and others). Start of sales in China through sales partner. First participation at the AACC. Staff of 60 employees.

2013
Foundation of ESfEQA GmbH as an accredited provider of external quality assessment testing schemes. Expansion of laboratory space and equipment. Employment of 5 further employees. First participation at the MEDICA.

2012
Expansion of the production capacity by 120 m². Foundation of DiaMex GmbH as a sister company with the aim of distributing manufacturer-independent controls. Acquisition of various infectiological test systems.


2011
Enlargement of the laboratory and cooling capacity. Creation of a donor center for patient samples in Western Africa. Certification of Biomex according to DIN EN ISO 13485:2003.

2010
Expansion of the Heidelberg site. Enlargement of the laboratory to 110 m². Operating permission for a microbiological L2 laboratory according to DIN 58956-3. Acquisition of various infectiological test systems. Certification according to DIN EN ISO 13485:2003. Recertification according to DIN EN ISO 9001:2008.

2009
Acquisition of the Seroconversion Panel of Life Therapeutics USA. Acquisition of the assets of SeroLife, Switzerland. Sale of the Munich Plasma Center to transfusion institute Synlab GmbH. Simultaneous opening of a plasma center in Munich for disease state plasmas. Start-up of a new plasma center in Heidelberg for the production of plasmas for diagnostic purposes (negative plasmas with an annual capacity of 25,000 l as well as disease state plasmas).

2008
Successful ISO 9001: 2000 recertification. Move into our own building with a size of 1200 m². Construction of our own modern biological-medical laboratory. Staff of 30 employees.

2007
Expansion of the plasma centre to produce specific normal plasma for the diagnostic industry. The production capacity is 25,000 litres p.a. The range of plasmas is added to in the areas of haemostasis plasmas (Coumadin, F VIII, Di-Dimer, Factor V Leiden and many others) and tropical diseases. Staff of 20 employees.

2006
Expansion of the plasma centre to produce specific normal plasma for the diagnostic industry. The production capacity is 25,000 litres p.a. The range of plasmas is added to in the areas of haemostasis plasmas (Coumadin, F VIII, Di-Dimer, Factor V Leiden and many others) and tropical diseases. Staff of 20 employees.

2005
Certification of the plasma center in accordance with ISO 9001: 2000

2004
On his 70th birthday, Mr Held decided to put Biomex GmbH’s destiny into younger hands. Since 01/07/2004, Mr Oliver Bošnjak, who holds degrees in chemistry and business, is the managing director of Biomex GmbH. In the course of the business transfer, the company's headquarter was also relocated from Mannheim to Heidelberg..

1989
Biomex GmbH was founded in 1989 by Mr Gerhard Held. In its early years, the company mainly supplied manufacturers of diagnostics with biological and biochemical raw materials such as blood plasma and bovine albumin. At the time of foundation, Mr. Held had more than 15 years of professional experience as a supplier of special medical diagnostic raw materials.